ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,631Medicare Part D Prescriptions Filled, Including Refills

Rank: 159 out of 663

$245K Total Retail Price of All Prescriptions

Rank: 305 out of 663

459 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

14% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 5,561 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 492 457 1 1
AMLODIPINE BESYLATE 316 269 2 5
ATENOLOL 313 288 3 10
OMEPRAZOLE 300 238 4 4
LISINOPRIL 289 255 5 2
LEVOTHROID 218 205 6 19
HYDROCODONE-ACETAMINOPHEN 190 154 S3 7 6
METFORMIN HCL 163 142 8 9
LEVOTHYROXINE SODIUM 156 151 9 3
LOSARTAN POTASSIUM 149 149 10 14
METOPROLOL TARTRATE 135 125 11 11
ALENDRONATE SODIUM 132 125 12 15
CITALOPRAM HBR 113 93 13 18
GLIPIZIDE 101 80 14 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 76 15 22
WARFARIN SODIUM 95 83 16 8
K-TAB 95 84 16 36
PRAVASTATIN SODIUM 93 64 18 21
PROAIR HFA 92 74 19 33
FUROSEMIDE 90 71 20 7
ATORVASTATIN CALCIUM 89 72 21 13
TRIAMTERENE-HCTZ 86 79 22 42
OXYCODONE-ACETAMINOPHEN 84 54 S2 23 26
HYDROCHLOROTHIAZIDE 81 75 24 12
FLUOXETINE HCL 81 54 24 32
TERAZOSIN HCL 79 60 26 38
NOVOLIN N 76 57 27 44
ALLOPURINOL 72 50 28 28
LOSARTAN-HYDROCHLOROTHIAZIDE 69 65 29 60
RANITIDINE HCL 67 45 30 31
ESTRADIOL 65 56 R 31 66
ZOLPIDEM TARTRATE 63 58 32 16
INSULIN SYRINGE 61 52 33 55
GABAPENTIN 57 30 34 20
FLUTICASONE PROPIONATE 57 53 34 27
PREDNISONE 54 47 36 39
PANTOPRAZOLE SODIUM 52 39 37 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.